Teva Pharmaceutical Industries Ltd (TEVA)
18.64
+0.19
(+1.03%)
USD |
NYSE |
Nov 04, 16:00
18.79
+0.15
(+0.80%)
After-Hours: 20:00
Teva Pharmaceutical Industries Gross Profit Margin (Quarterly): 48.61% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 48.61% |
| March 31, 2024 | 46.37% |
| December 31, 2023 | 54.18% |
| September 30, 2023 | 48.08% |
| June 30, 2023 | 46.32% |
| March 31, 2023 | 43.20% |
| December 31, 2022 | 45.58% |
| September 30, 2022 | 46.43% |
| June 30, 2022 | 47.40% |
| March 31, 2022 | 47.53% |
| December 31, 2021 | 50.00% |
| September 30, 2021 | 46.17% |
| June 30, 2021 | 47.90% |
| March 31, 2021 | 47.16% |
| December 31, 2020 | 46.00% |
| September 30, 2020 | 46.56% |
| June 30, 2020 | 45.56% |
| March 31, 2020 | 47.35% |
| December 31, 2019 | 43.83% |
| September 30, 2019 | 44.71% |
| June 30, 2019 | 45.33% |
| March 31, 2019 | 44.76% |
| December 31, 2018 | 49.57% |
| September 30, 2018 | 43.65% |
| June 30, 2018 | 43.25% |
| Date | Value |
|---|---|
| March 31, 2018 | 45.71% |
| December 31, 2017 | 46.67% |
| September 30, 2017 | 47.18% |
| June 30, 2017 | 49.91% |
| March 31, 2017 | 50.25% |
| December 31, 2016 | 49.04% |
| September 30, 2016 | 50.35% |
| June 30, 2016 | 57.11% |
| March 31, 2016 | 58.02% |
| December 31, 2015 | 58.33% |
| September 30, 2015 | 57.45% |
| June 30, 2015 | 58.44% |
| March 31, 2015 | 56.92% |
| December 31, 2014 | 55.90% |
| September 30, 2014 | 55.54% |
| June 30, 2014 | 52.75% |
| March 31, 2014 | 53.93% |
| December 31, 2013 | 53.30% |
| September 30, 2013 | 51.99% |
| June 30, 2013 | 52.66% |
| March 31, 2013 | 52.85% |
| December 31, 2012 | 53.06% |
| September 30, 2012 | 52.31% |
| June 30, 2012 | 53.20% |
| March 31, 2012 | 51.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
43.20%
Minimum
Mar 2023
54.18%
Maximum
Dec 2023
47.06%
Average
46.56%
Median
Sep 2020
Gross Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 91.11% |
| Compugen Ltd | 76.84% |
| Pluri Inc | -- |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.36% |
| Return on Assets | -1.12% |
| Return on Invested Capital | -1.75% |
| Profit Margin (Quarterly) | -20.32% |
| Operating Margin (Quarterly) | 19.60% |
| Return on Net Operating Assets | -1.24% |